{"address1": "19805 North Creek Parkway", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "877 262 7123", "website": "https://www.cocrystalpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Roger D. Kornberg Ph.D.", "age": 77, "title": "Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 160500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sam  Lee Ph.D.", "age": 64, "title": "Co-Founder, Co-CEO & President", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 610459, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James J. Martin CPA, M.B.A.", "age": 57, "title": "Co-CEO, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 610459, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.42, "open": 1.4, "dayLow": 1.4, "dayHigh": 1.4899, "regularMarketPreviousClose": 1.42, "regularMarketOpen": 1.4, "regularMarketDayLow": 1.4, "regularMarketDayHigh": 1.4899, "payoutRatio": 0.0, "beta": 2.347, "forwardPE": -0.6425339, "volume": 4474, "regularMarketVolume": 4474, "averageVolume": 25191, "averageVolume10days": 16200, "averageDailyVolume10Day": 16200, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 14446796, "fiftyTwoWeekLow": 1.35, "fiftyTwoWeekHigh": 3.26, "fiftyDayAverage": 1.7872, "twoHundredDayAverage": 1.96765, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3301781, "profitMargins": 0.0, "floatShares": 7012997, "sharesOutstanding": 10173800, "sharesShort": 1446, "sharesShortPriorMonth": 14367, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.31851998, "heldPercentInstitutions": 0.06993, "shortRatio": 0.07, "shortPercentOfFloat": 0.0002, "impliedSharesOutstanding": 10173800, "bookValue": 1.249, "priceToBook": 1.1369095, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -18702000, "trailingEps": -1.84, "forwardEps": -2.21, "lastSplitFactor": "1:12", "lastSplitDate": 1665446400, "enterpriseToEbitda": -0.164, "52WeekChange": -0.0069929957, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.42, "targetHighPrice": 10.0, "targetLowPrice": 7.0, "targetMeanPrice": 8.33333, "targetMedianPrice": 8.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 13020000, "totalCashPerShare": 1.28, "ebitda": -20176000, "totalDebt": 1875000, "quickRatio": 7.018, "currentRatio": 7.318, "debtToEquity": 14.76, "returnOnAssets": -0.51984, "returnOnEquity": -0.86197996, "grossProfits": -14767000, "freeCashflow": -10829250, "operatingCashflow": -16651000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "COCP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1329921000000, "marketState": "PRE", "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.42, "shortName": "Cocrystal Pharma, Inc.", "longName": "Cocrystal Pharma, Inc.", "regularMarketChange": 0.0, "regularMarketDayRange": "1.4 - 1.4899", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 25191, "fiftyTwoWeekLowChange": 0.06999993, "fiftyTwoWeekLowChangePercent": 0.0518518, "fiftyTwoWeekRange": "1.35 - 3.26", "fiftyTwoWeekHighChange": -1.84, "fiftyTwoWeekHighChangePercent": -0.5644172, "fiftyTwoWeekChangePercent": -0.6992996, "dividendDate": 1516752000, "earningsTimestamp": 1743422400, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.84, "epsForward": -2.21, "epsCurrentYear": -2.095, "priceEpsCurrentYear": -0.6778043, "fiftyDayAverageChange": -0.36720002, "fiftyDayAverageChangePercent": -0.20546107, "twoHundredDayAverageChange": -0.5476501, "twoHundredDayAverageChangePercent": -0.278327, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_49062639", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cocrystal Pharma", "trailingPegRatio": null}